315 related articles for article (PubMed ID: 3779631)
1. Effects of concomitant and sinecomitant immunity on postsurgical metastasis in mice.
Nomi S; Naito K; Kahan BD; Pellis NR
Cancer Res; 1986 Dec; 46(12 Pt 1):6111-5. PubMed ID: 3779631
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapeutic effects of partially purified tumor-specific transplantation antigens on pulmonary metastases of a 3-methylcholanthrene-induced sarcoma in mice: a preliminary report.
Tanaka T; Pellis NR; Kahan BD
J Natl Cancer Inst; 1982 Nov; 69(5):1121-6. PubMed ID: 6957656
[TBL] [Abstract][Full Text] [Related]
3. Retardation of postsurgical metastases with the use of extracted tumor-specific transplantation antigens and cyclophosphamide.
Nomi S; Pellis NR; Kahan BD
J Natl Cancer Inst; 1984 Oct; 73(4):943-50. PubMed ID: 6237215
[TBL] [Abstract][Full Text] [Related]
4. Intrasplenic administration of interleukin-2 to potentiate specific chemoimmunotherapy in tumor-bearing mice.
Nomi S; Naito K; Kahan BD; Pellis NR
Cancer Res; 1986 Nov; 46(11):5606-10. PubMed ID: 2875791
[TBL] [Abstract][Full Text] [Related]
5. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.
Naito K; Pellis NR; Kahan BD
Cancer Res; 1988 Jan; 48(1):101-8. PubMed ID: 3257158
[TBL] [Abstract][Full Text] [Related]
6. Stimulation or inhibition of immune resistance against metastatic or local growth of a C3H mammary carcinoma.
Vaage J; Agarwal S
Cancer Res; 1976 May; 36(5):1831-6. PubMed ID: 1268839
[TBL] [Abstract][Full Text] [Related]
7. Afferent and efferent specificity in the induction and elicitation of parental cross-protective immunity by an immunogenic murine tumor variant: associative recognition of a unique tumor-specific antigen on somatic cell hybrids.
LeGrue SJ; Ananthaswamy HN; Simcik WJ
Cancer Res; 1989 Sep; 49(17):4747-51. PubMed ID: 2474372
[TBL] [Abstract][Full Text] [Related]
8. Immunogenic variants of a murine fibrosarcoma induced by mutagenesis: requirement of viable cells for antigen-specific cross-protection.
LeGrue SJ; Simcik WJ; Frost P
Cancer Res; 1987 Aug; 47(16):4413-6. PubMed ID: 3607772
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of a carcinogen-induced murine sarcoma with soluble tumor-specific transplantation antigens.
Kahan BD; Tanaka T; Pellis NR
J Natl Cancer Inst; 1980 Nov; 65(5):1001-4. PubMed ID: 6159495
[TBL] [Abstract][Full Text] [Related]
10. [Subcutaneous injection of spleen cells from mice bearing large methylcholanthrene-induced sarcoma enhances subcutaneous tumors and artificial pulmonary metastases].
Tsuchiya K; Yamagishi H; Hamada H; Komichi H; Oka T; Tanaka T; Inaba S
Nihon Geka Gakkai Zasshi; 1987 Jul; 88(7):826-31. PubMed ID: 2444868
[TBL] [Abstract][Full Text] [Related]
11. Therapy of artificial and spontaneous metastases of murine tumors with maleic anhydride-divinyl ether-2.
Milas L; Hersh EM; Hunter N
Cancer Res; 1981 Jun; 41(6):2378-85. PubMed ID: 7237436
[TBL] [Abstract][Full Text] [Related]
12. [Induction of immunogenic variant of a murine fibrosarcoma].
Kobayashi M; Yamagishi H; Nomi S; Ueda Y; Hayashi T; Oka T
Nihon Geka Gakkai Zasshi; 1992 Nov; 93(11):1372-7. PubMed ID: 1448043
[TBL] [Abstract][Full Text] [Related]
13. Specific chemoimmunotherapy in tumor-bearing mice with extracted antigen, cyclophosphamide, and intrasplenic administration of interleukin-2.
Kahan BD; Nomi S; Pellis NR
Cancer; 1986 Feb; 57(3):477-83. PubMed ID: 3484658
[TBL] [Abstract][Full Text] [Related]
14. Studies on the antitumor activities of pyrimidinone-interferon inducers. I. Effect against artificial and spontaneous lung metastases of murine tumors.
Milas L; Hersh EM; Stringfellow DA; Hunter N
J Natl Cancer Inst; 1982 Jan; 68(1):139-45. PubMed ID: 6172625
[TBL] [Abstract][Full Text] [Related]
15. Tumor-specific immune responsiveness of the tumor-bearing host.
Burk MW; Yu S; McKhann CF
Isr J Med Sci; 1976; 12(4-5):360-8. PubMed ID: 939694
[TBL] [Abstract][Full Text] [Related]
16. Biochemical characterization of 1-butanol-extracted murine tumor-specific transplantation antigens.
LeGrue SJ; Pellis NR; Riley LB; Kahan BD
Cancer Res; 1985 Jul; 45(7):3164-72. PubMed ID: 2408745
[TBL] [Abstract][Full Text] [Related]
17. Development of concomitant immunity in mice bearing the weakly immunogenic line 1 lung carcinoma.
Yuhas JM; Pazmiño NH; Wagner E
Cancer Res; 1975 Jan; 35(1):237-41. PubMed ID: 162863
[TBL] [Abstract][Full Text] [Related]
18. [Specific active immunotherapy of murine methylcholanthrene-induced sarcoma using a partially purified soluble tumor specific transplantation antigens].
Tanaka T; Yamagishi H; Inaba S; Kobayashi M; Kurioka H; Naito K; Hashimoto I
Nihon Geka Gakkai Zasshi; 1983 Apr; 84(4):282-94. PubMed ID: 6201713
[TBL] [Abstract][Full Text] [Related]
19. Analysis of gp74 expression by transformed rat fibroblasts from experimental pulmonary metastases following specific ricin A-chain immunotoxin therapy.
Roth JA; Thomsen S; Fry KD; Scannon P; Chang C
Cancer Res; 1989 Oct; 49(20):5708-12. PubMed ID: 2676148
[TBL] [Abstract][Full Text] [Related]
20. Persistence of immunogenic pulmonary metastases in the presence of protective anti-melanoma immunity.
Donawho CK; Pride MW; Kripke ML
Cancer Res; 2001 Jan; 61(1):215-21. PubMed ID: 11196164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
